ARTL - Artelo Biosciences Inc
1.17
0.030 2.564%
Share volume: 273,235
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$1.14
0.03
0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-03-2025 | 05-13-2025 | 08-13-2025 | 11-12-2025 | 02-24-2026 | |
| Assets | ||||||
| Total Assets | 4.698 M | 3.515 M | 4.357 M | 4.267 M | 2.801 M | |
| Current Assets | 2.557 M | 1.382 M | 2.233 M | 1.827 M | 695.000 K | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 424.000 K | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.338 M | 746.000 K | 2.066 M | 1.720 M | 600.000 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 2.141 M | 2.133 M | 2.124 M | 2.440 M | 2.106 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 4.698 M | 3.515 M | 4.357 M | 4.267 M | 2.801 M | |
| Total liabilities | 1.841 M | 2.863 M | 5.763 M | 4.900 M | 4.073 M | |
| Total current liabilities | 1.772 M | 2.804 M | 5.712 M | 4.860 M | 4.044 M | |
| Accounts Payable | 1.679 M | 2.509 M | 4.841 M | 3.868 M | 3.035 M | |
| Other liabilities | 69.000 K | 59.000 K | 51.000 K | 40.000 K | 29.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 69.000 K | 59.000 K | 51.000 K | 40.000 K | 29.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.857 M | 652.000 K | -1.406 M | -633.000 K | -1.272 M | |
| Common stock | 53.195 M | 53.387 M | 54.618 M | 58.493 M | 62.015 M | |
| Retained earnings | -50.136 M | -52.508 M | -55.729 M | -58.849 M | -63.015 M |